ACURX PHARMACEUTICALS INC (ACXP)
US00510M1045 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.44M | -14.58M | -12.09M | -12.75M | -4.60M | |||
| Change In Working Capital | -18.16K | 1.01M | 1.25M | 140.00K | -800.00K | |||
| Other non cash items | 4.12M | 3.77M | 3.30M | 7.59M | 2.05M | |||
| OPERATING CASH FLOW | -12.33M | -9.80M | -7.54M | -5.01M | -3.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 70.00K | |||
| Stock Issued/Repurchased | 11.04M | 8.16M | 3.70M | 14.80M | 3.98M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 11.04M | 8.16M | 3.70M | 14.80M | 4.04M | |||
| CHANGE IN CASH | -1.29M | -1.64M | -3.85M | 9.78M | 690.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.33M | -9.80M | -7.54M | -5.01M | -3.35M | |||
| FREE CASH FLOW | -12.33M | -9.80M | -7.54M | -5.01M | -3.35M | |||
All data in USD